Clavimox

Clavimox

amoxicillin + clavulanic acid

Manufacturer:

Swiss Parenterals

Distributor:

International Apex
Concise Prescribing Info
Contents
Co-amoxiclav (amoxicillin & clavulanic acid). Per 1.2 g vial Amoxicillin 1 g, clavulanic acid 200 mg
Indications/Uses
Treatment of infections caused by susceptible organisms including upper & lower resp tract, GUT, skin & soft tissue, bone & joint infections & septicemia.
Dosage/Direction for Use
Usual dose: 250-500 mg 8 hrly. Childn ≤10 yr 125-250 mg 8 hrly, <20 kg 20-40 mg/kg daily in divided doses 8 hrly. Infant <3 mth Max: 30 mg/kg/day in divided doses 12 hrly. Duration should not exceed 14 days.
Adverse Reactions
Hepatitis, cholestatic jaundice, skin rashes either urticarial or maculopapular, GI effects eg, diarrhea, nausea, vomiting. Pseudomembranous colitis.
Drug Interactions
Allopurinol.
MIMS Class
ATC Classification
J01CR02 - amoxicillin and beta-lactamase inhibitor ; Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
Presentation/Packing
Form
Clavimox powd for inj
Packing/Price
(vial) 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in